Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0641
D

Inaccurate MDS Assessment Due to Misclassification of Injectable Medication

Yoakum, Texas Survey Completed on 05-30-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that a resident's assessment accurately reflected their medication administration status. Specifically, a quarterly Minimum Data Set (MDS) assessment for one resident was incorrectly coded to indicate that the resident had received an insulin injection during the look-back period. Review of the resident's medical records, including physician orders and medication administration records, showed that the resident was prescribed and received Trulicity, a non-insulin injectable medication, for Type 2 diabetes mellitus. There was no order or documentation of insulin administration for this resident during the relevant period. Interviews with the MDS LVN, Regional Care Manager, and Administrator revealed that the nursing staff was unaware that Trulicity is not classified as insulin, leading to the incorrect coding on the MDS assessment. The facility relied on the RAI manual for MDS coding guidance and did not have a separate policy addressing this issue. The error was identified through review of the resident's records and staff interviews, confirming that the assessment did not accurately reflect the resident's actual medication regimen.

An unhandled error has occurred. Reload 🗙